A startup is developing “organ sacks” — brainless, nonsentient biological structures
A startup is developing “organ sacks” — brainless, nonsentient biological structures — to solve organ transplant shortages.
Bay Area-based startup R3 Bio is pitching a provocative solution to the ethical and logistical hurdles of animal research: “organ sacks.”
These engineered structures are designed to house fully functional organ systems but lack a brain, rendering them nonsentient and incapable of feeling pain.
Developed using a combination of stem-cell technology and gene editing, these “bodyoids” aim to provide a scalable and ethical alternative to nonhuman primates, which are increasingly scarce and expensive following international export bans. By replicating the complexity of whole organs—including vascular systems—without the consciousness of a living animal, R3 Bio hopes to modernize drug development and align with the federal government’s phase-out of traditional animal experimentation.
Beyond laboratory testing, the long-term vision for these nonsentient structures involves human regenerative medicine. With over 100,000 people currently on organ transplant waiting lists in the U.S. alone, organ sacks could eventually serve as a reliable, ethically sourced reservoir for life-saving tissues. While other researchers explore xenotransplantation using pig organs, R3 Bio’s approach targets the root of the shortage by attempting to grow human-compatible systems from scratch. While the concept raises complex bioethical questions regarding the creation and maintenance of these entities, proponents argue that “replacement” is a superior strategy to “repair” in treating chronic disease and managing the aging process.
source: Mullin, E. This Biotech Startup Wants to Replace Lab Animals With Brainless ‘Organ Sacks’. WIRED.
